Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Accelerated iTBS for Post Partum Depression

NCT: NCT03417960 · RECRUITING

NCT IDNCT03417960
StatusRECRUITING
Start Date2018-01-24
Completion2027-08-30

Brief Summary

Study 1: The investigators are studying the feasibility and tolerability of 10x/day intermittent theta burst (excitatory) transcranial magnetic stimulation to the left dorsolateral prefrontal cortex over the course of 6 days for women with post-partum depression. The investigators further aim to characterize the anticipated anti-depressant effect of this treatment paradigm. Study 2: The investigators are studying the feasibility and tolerability of 12 sessions/day of intermittent theta burse (excitatory) transcranial magnetic stimulation to the left dorsolateral prefrontal cortex over 5 days for women with post-partum depression. The investigators aim to compare the two different treatment schedules.

Frequently Asked Questions

What is Accelerated iTBS for Post Partum Depression?

Accelerated iTBS for Post Partum Depression is a clinical trial registered under NCT03417960. Current status: RECRUITING.

What is the status of NCT03417960?

The current status of NCT03417960 (Accelerated iTBS for Post Partum Depression) is: RECRUITING.

When did Accelerated iTBS for Post Partum Depression start?

Accelerated iTBS for Post Partum Depression started on 2018-01-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.